GM28411
LCL from B-Lymphocyte
Description:
MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH ATAXIA
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
German-English
|
Country of Origin
|
USA
|
Family History
|
Y
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Gene |
CACNA1A |
Chromosomal Location |
19p13.13 |
Allelic Variant 1 |
601011.0018; MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH ATAXIA |
Identified Mutation |
ARG583GLN; c.1748(isoform 1)G>A; In 2 Italian sisters with familial hemiplegic migraine (FHM1; 141500) and late-onset cerebellar ataxia and cerebellar atrophy, Battistini et al. (1999) identified an arg583-to-gln (R583Q) mutation in a putative voltage sensor domain of the CACNA1A gene. The frequency and severity of the attacks increased near the sixth decade for both patients, when the cerebellar signs developed. Acetazolamide was effective prophylactic therapy.
Terwindt et al. (2002) studied 27 patients with sporadic hemiplegic migraine and found the R583Q mutation in a 16-year-old boy with no cerebellar signs.
In a large Portuguese family in which 17 patients over 4 generations were affected with hemiplegic migraine and/or progressive cerebellar ataxia-6 (SCA6; 183086), Alonso et al. (2003) found that all patients shared a common haplotype and carried the R583Q mutation. Mean age at onset for hemiplegic migraine symptoms was in the second decade and onset of cerebellar signs was approximately 20 years later. Four patients, all under the age of 18 years, had only hemiplegic migraine, 8 patients had isolated progressive cerebellar ataxia, and 5 patients had both hemiplegic migraine and cerebellar ataxia. Several patients reported symptoms triggered by minor head trauma. Alonso et al. (2003) postulated that the mutation, which occurs in a transmembrane segment of the voltage sensor of the channel, may cause a shift in the voltage dependence of the channel, leading to an increase in intracellular calcium. They suggested that episodic ataxia-2 (EA2; 108500), SCA6, and familial hemiplegic migraine are not only allelic disorders, but may be the same disorder with great phenotypic variability.
De Vries et al. (2007) identified a 2021G-A transition in the CACNA1A gene, resulting in an R583Q substitution, in a patient who developed FHM at age 13 years. The mutation was also identified in his mother, who had migraine with aura. The findings suggested either reduced penetrance or a common pathogenetic mechanism for both hemiplegic and nonhemiplegic migraine. |
Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
14 YR |
Sex |
Female |
Age of Onset(If not a control) |
12 YR |
Age at Diagnosis(If not a control) |
12 YR |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
NEXT GENERATION SEQUENCING (NGS) USING GENOMIC DNA REVEALED AN AUTOSOMAL DOMINANT HETEROZYGOUS PATHOGENIC MISSENSE MUTATION IN CACNA1A: C.1748(ISOFORM1)G>A (P.ARG583GLN); ALIGNMENT TO GRCH37/HG19 GENOMIC BUILD; GENOME ANALYSIS TOOLKIT 2.3-9 |
Zygosity: |
Heterozygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
12 YEARS |
Age at Diagnosis: |
12 YEARS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
|
Neurological Symptoms |
|
|
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Developmental Milestones |
|
|
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Additional Information |
Testing Performed |
Neurological Testing: |
EKG - NORMAL; MRI - NORMAL CEREBELLUM |
Treatments and Assistive Devices |
|
|
Medications |
|
TOPIRAMATE |
Family History |
|
FATHER HAS ATAXIA; GRANDMOTHER, PATERNAL AUNT, AND GREAT GRANDMOTHER ALL HAVE ATAXIA AND FAMILIAL HEMIPLEGIC MIGRAINES. |
Remarks |
Clinically affected; see "Phenotypic Data" tab. |
Gene Cards |
CACNA1A |
Gene Ontology |
GO:0003677 DNA binding |
|
GO:0005245 voltage-gated calcium channel activity |
|
GO:0005509 calcium ion binding |
|
GO:0005634 nucleus |
|
GO:0005891 voltage-gated calcium channel complex |
|
GO:0006355 regulation of transcription, DNA-dependent |
|
GO:0006812 cation transport |
|
GO:0006816 calcium ion transport |
|
GO:0007204 cytosolic calcium ion concentration elevation |
|
GO:0007268 synaptic transmission |
|
GO:0007399 neurogenesis |
|
GO:0008219 cell death |
|
GO:0016021 integral to membrane |
NCBI Gene |
Gene ID:773 |
NCBI GTR |
141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1 |
|
601011 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A |
OMIM |
141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1 |
|
601011 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A |
Omim Description |
FHM |
|
MIGRAINE, FAMILIAL HEMIPLEGIC 1; MHP1 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|